Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03662009 · ClinicalTrials.gov registry record

Multi-limb Dual-task Control in Parkinson's Disease

A clinical trial, sponsored by A.T. Still University of Health Sciences.

Completed
Registry status
60
Enrollment target

NCT03662009: Completed study, sponsored by A.T. Still University of Health Sciences.

NCT03662009 is a clinical trial that has completed, run by A.T. Still University of Health Sciences. The registered enrollment target is 60 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03662009 has completed, sponsored by A.T. Still University of Health Sciences.

COMPLETED
Registry status
60 participants
Enrollment target

Study Summary

People with Parkinson disease commonly experience difficulty driving, which requires the arms and legs to do different tasks simultaneously. Driving difficulties can lead to isolation, depression, loss of independence and mobility, and increased incidence of car accidents. Through understanding the impact of Parkinson disease on mechanisms underlying attention and multi-limb control, training and rehabilitation programs can better focus on the needs of drivers with Parkinson disease. The proposed study aims to address this need by taking measures of simulated driving at one point in time. Subjects with PD are tested at a single time point when they are at their "best" point in their day and on another day when they are at their worst and are about to take their next dose of medication. Healthy age-matched subjects are not taking anti-parkinson medication so are tested at only one point.

Primary Outcome

The Dual Task Effect is the performance measure of the arm and foot task, respectively, in the dual task relative to the single task, expressed as a percentage.

Interventions

  • OTHER multilimb dual task

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2017-09-01
Est. Completion 2020-11-30

What the finished NCT03662009 record still lists

NCT03662009 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 60 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which multilimb dual task is the first listed.

NCT03662009 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03662009 about?

NCT03662009 is a clinical study titled "Multi-limb Dual-task Control in Parkinson's Disease". People with Parkinson disease commonly experience difficulty driving, which requires the arms and legs to do different tasks simultaneously. Driving difficulties can lead to isolation, depression, loss of independence and mobility, and increased incidence of car accidents. Through understanding the ...

What is the current status of trial NCT03662009?

This trial is currently completed. The enrollment target is 60 participants. The study started on 2017-09-01. Estimated completion is 2020-11-30.

What interventions are being tested in trial NCT03662009?

The interventions under investigation include: multilimb dual task (OTHER).

Who is sponsoring clinical trial NCT03662009?

This trial is sponsored by A.T. Still University of Health Sciences, which has 16 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03662009, the US trial registry maintained by the National Library of Medicine. NCT03662009 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.